Michael J. Welch

Q: What Schools Are Affiliated With Michael J. Welch

Michael J. Welch is affiliated with the following schools: Mallinckrodt Institute of Radiology, Texas A&M University, University of the Witwatersrand

Michael J. Welch's AcademicInfluence.com Rankings

Michael J. Welch

Chemistry

#1313

World Rank

#2001

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Why Is Michael J. Welch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael J. Welch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984) (982)
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. (2002) (935)
Gold nanocages as photothermal transducers for cancer treatment. (2010) (618)
Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. (1976) (482)
Efficient production of high specific activity 64Cu using a biomedical cyclotron. (1997) (473)
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. (2001) (450)
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy (2005) (434)
Breast cancer: PET imaging of estrogen receptors. (1988) (401)
Quantification of regional myocardial blood flow in vivo with H215O. (1984) (389)
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. (2001) (383)
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM (2003) (359)
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging (1999) (350)
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. (2003) (331)
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. (1999) (327)
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. (1995) (311)
Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. (1977) (308)
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. (2003) (300)
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. (2000) (295)
Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. (1983) (286)
Positron emission tomographic assessment of ”metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy (1999) (276)
Tumor Localization of 16β-18F-Fluoro-5α-Dihydrotestosterone Versus 18F-FDG in Patients with Progressive, Metastatic Prostate Cancer (2004) (268)
Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats. (1984) (262)
Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. (1976) (249)
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships (2002) (245)
Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart (2007) (242)
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. (2001) (237)
Positron Tomographic Assessment of 16α-[18F] Fluoro-17β-Estradiol Uptake in Metastatic Breast Carcinoma (1991) (233)
Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis (2009) (227)
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. (1982) (214)
Positron tomographic assessment of androgen receptors in prostatic carcinoma (2005) (211)
Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic Applications (2010) (211)
Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone) (2008) (210)
An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. (2005) (210)
Inorganic nanoparticle-based contrast agents for molecular imaging. (2010) (207)
Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy. (2001) (204)
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. (1996) (204)
In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. (2010) (201)
Small animal imaging. current technology and perspectives for oncological imaging. (2002) (201)
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. (2001) (199)
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. (2002) (198)
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer (2009) (193)
Positron Emission Tomographic Measurement of Cerebral Blood Flow and Permeability—Surface Area Product of Water Using [15O]Water and [11C]Butanol (1987) (192)
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor mo (2005) (188)
External Detection and Visualization of Myocardial Ischemia with 11C‐Substrates in Vitro and in Vivo (1976) (182)
Indium‐III: a New Radionuclide Label for Studying Human Platelet Kinetics (1979) (179)
Handbook of Radiopharmaceuticals: Radiochemistry and Applications (2002) (173)
An Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix (2008) (172)
Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. (2007) (160)
Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study (2008) (160)
64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. (2005) (160)
Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. (1993) (157)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas (2012) (155)
Quantification of Infarction in Cross Sections of Canine Myocardium In Vivo with Positron Emission Transaxial Tomography and 11C‐Palmitate (1977) (153)
Indium-111-labeled cellular blood components: mechanism of labeling and intracellular location in human neutrophils. (1977) (151)
MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. (2003) (149)
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. (1990) (148)
Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. (1980) (148)
The in vivo behavior of copper-64-labeled azamacrocyclic complexes. (1998) (147)
Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. (2012) (146)
Detection of Remote Myocardial Infarction in Patients with Positron Emission Transaxial Tomography and Intravenous “IC-Palmitate (1977) (142)
Copper-64-labeled antibodies for PET imaging. (1992) (141)
The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. (1970) (140)
High purity production and potential applications of copper-60 and copper-61. (1999) (139)
The Dependence of Accumulation of 13NH3 by Myocardium on Metabolic Factors and Its Implications for Quantitative Assessment of Perfusion (1980) (138)
The determination of regional cerebral blood flow by means of water labeled with radioactive oxygen 15. (1969) (136)
Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography (1986) (136)
In vitro and in vivo evaluation of copper-64-octreotide conjugates. (1995) (136)
Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. (2008) (133)
Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. (1982) (133)
18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. (2007) (131)
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. (1995) (131)
Redox-active metal complexes for imaging hypoxic tissues: structure–activity relationships in copper(II) bis(thiosemicarbazone) complexes (1998) (131)
Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells (2001) (130)
Gallium radiopharmaceutical chemistry. (1989) (130)
In Vivo Imaging of 64Cu-Labeled Polymer Nanoparticles Targeted to the Lung Endothelium (2007) (126)
Tomographic images of blood pool and perfusion in brain and heart. (1976) (124)
Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. (1996) (120)
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron. (2003) (120)
Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. (2007) (118)
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. (2003) (118)
SCINTIGRAPHIC DETECTION OF ATHEROSCLEROTIC LESIONS AND VENOUS THROMBI IN MAN BY INDIUM-111-LABELLED AUTOLOGOUS PLATELETS (1978) (117)
Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. (1999) (117)
11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. (1990) (116)
Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. (2001) (116)
Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. (1986) (115)
Development and evaluation of a candidate reference measurement procedure for the determination of 19-norandrosterone in human urine using isotope-dilution liquid chromatography/tandem mass spectrometry. (2005) (114)
Measurement of input functions in rodents: challenges and solutions. (2005) (114)
Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. (2012) (113)
In vivo measurement of brain glucose transport and metabolism employing glucose- -11C. (1975) (112)
Hair analysis for drugs of abuse: evaluation of analytical methods, environmental issues, and development of reference materials. (1993) (112)
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH (2005) (111)
Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. (1991) (111)
Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. (1996) (110)
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. (2003) (108)
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. (2004) (108)
A simple 18O water target for 18F production. (1984) (108)
Development and evaluation of a candidate reference measurement procedure for the determination of progesterone in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry. (2006) (107)
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. (2005) (107)
PET imaging of hypoxia. (2001) (106)
Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. (2006) (104)
A rapid and efficient method for the fluoroalkylation of amines and amides. Development of a method suitable for incorporation of the short-lived positron emitting radionuclide fluorine-18 (1987) (103)
External assessment of myocardial metabolism with C-11 palmitate in vivo. (1980) (100)
LOCALIZATION OF VIABLE, ISCHEMIC MYOCARDIUM BY POSITRON‐EMISSION TOMOGRAPHY WITH 11C‐PALMITATE (1981) (100)
An improved [18O]water target for [18F]fluoride production. (1985) (100)
The chemistry of gallium and indium as related to radiopharmaceutical production. (1981) (98)
Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. (2006) (98)
Fluorine-18 labeling of proteins. (1987) (96)
Basic characterization of 64Cu-ATSM as a radiotherapy agent. (2005) (96)
New approaches to the synthesis of 3-deoxy-3-fluoro-D-glucose (1978) (96)
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies. (2005) (96)
Determination of serum creatinine by isotope dilution mass spectrometry as a candidate definitive method. (1984) (95)
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). (2002) (94)
Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings. (2012) (94)
Gallium-68 labeling of albumin and albumin microspheres. (1979) (93)
Effect of Flow‐Independent Reduction of Metabolism on Regional Myocardial Clearance of 11C‐Palmitate (1982) (93)
Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography. (2007) (92)
Evaluation of62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer (2000) (91)
Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. (2008) (90)
Preparation and evaluation of 111In-labeled leukocytes as an abscess imaging agent in dogs. (1976) (90)
Minimally invasive method of determining blood input function from PET images in rodents. (2006) (89)
Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. (2003) (88)
Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. (2011) (88)
Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. (1996) (88)
Studies of radioiodinated fibrinogen. I. Physicochemical properties of the ICl, chloramine-T, and electrolytic reaction products. (1972) (88)
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. (2008) (87)
Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. (1989) (86)
Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. (1990) (83)
Development of a Standard Reference Material for metabolomics research. (2013) (83)
Fluorine-18-labeled androgens: radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer. (1992) (83)
Scintigraphic Detection of Carotid Atherosclerosis with Indium‐111‐labeled Autologous Platelets (1980) (83)
Comparison of Molecular Markers of Hypoxia and Imaging with 60Cu-ATSM in Cancer of the Uterine Cervix (2007) (82)
Development and evaluation of a reference measurement procedure for the determination of total 3,3',5-triiodothyronine in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. (2004) (81)
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation. (2004) (80)
Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior. (1996) (79)
A novel hexachelating amino-thiol ligand and its complex with gallium(III) (1990) (79)
Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. (2010) (79)
A new germanium-63/gallium-68 generator. (1978) (79)
Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging (2007) (77)
Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas. (1991) (77)
Measurements of pulmonary vascular permeability with PET and gallium-68 transferrin. (1987) (76)
Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM. (1990) (76)
A NEW 68Ge/68Ga RADIOISOTOPE GENERATOR SYSTEM FOR PRODUCTION OF 68Ga IN DILUTE HCI (1981) (76)
Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors. (2002) (76)
Certification of creatinine in a human serum reference material by GC-MS and LC-MS. (2007) (76)
Preparation of high specific activity (86)Y using a small biomedical cyclotron. (2005) (76)
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. (2009) (75)
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer. (2004) (75)
Comparison of two isotope dilution/mass spectrometric methods for determination of total serum cholesterol. (1982) (74)
Characterization of nontransmural myocardial infarction by positron-emission tomography. (1982) (74)
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents. (2005) (73)
The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer. (1997) (73)
Transaxial tomographic imaging of canine myocardium with 11C-palmitic acid. (1977) (72)
Preparation of short half-lived radioactive gases for medical studies. (1968) (72)
Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. (2009) (71)
Folate-mediated Cell Uptake of Shell-crosslinked Spheres and Cylinders. (2008) (71)
16α-[77Br]Bromoestradiol-17β: A High Specific-Activity, Gamma-Emitting Tracer with Uptake in Rat Uterus and Induced Mammary Tumors (1981) (71)
Synthesis of an Estrogen Receptor β-Selective Radioligand: 5-[18F]Fluoro-(2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentanenitrile and Comparison of in Vivo Distribution with 16α-[18F]Fluoro-17β-estradiol (2005) (71)
Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione (2012) (71)
Determination of serum cholesterol by a modification of the isotope dilution mass spectrometric definitive method. (1989) (71)
[18F]-labeled 3-deoxy-3-fluoro-D-glucose: synthesis and preliminary biodistribution data. (1978) (71)
Synthesis of 16-fluoroestrogens by unusually facile fluoride ion displacement reactions: prospects for the preparation of fluorine-18 labeled estrogens (1984) (70)
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. (1991) (70)
Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. (1989) (69)
64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistry. (2012) (69)
Candidate reference method for total thyroxine in human serum: use of isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. (2002) (69)
Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186. (1992) (68)
Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors (1980) (67)
Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation (2008) (67)
Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thrombosis. (1978) (67)
Preparation, biodistribution, and small animal PET of 45Ti-transferrin. (2005) (66)
Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator. (2007) (66)
Measurement of regional substrate utilization rates by emission tomography. (1978) (66)
Differences in the sites of iodination of proteins following four methods of radioiodination. (1977) (66)
Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium. (1989) (66)
Quantification of Regional Myocardial Perfusion With Generator‐Produced 62Cu‐PTSM and Positron Emission Tomography (1993) (65)
Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol. (1984) (65)
Measurement of regional pulmonary blood flow with PET. (1995) (64)
NCA 16α-[18F]fluoroestradiol-17β: The effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity (1986) (64)
Preparation of glucose labeled with 20-minute half-lived carbon-11. (1971) (64)
Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer (2012) (64)
16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs. (1982) (63)
Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using isotope dilution liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry. (2004) (63)
Gallium-68 labeled red cells and platelets: new agents for positron tomography. (1977) (63)
Methodology for the synthesis and specific activity determination of 16α-[77Br]-Bromoestradiol-17 β and 16α-[77Br]-11 β-methoxyestradiol-17 β, Two estrogen receptor-binding radiopharmaceuticals (1982) (62)
Targeting Angiogenesis Using a C-Type Atrial Natriuretic Factor–Conjugated Nanoprobe and PET (2011) (62)
Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. (1983) (62)
Synthesis, characterization, and solid-state structure of a new hexachelating ligand and its complex with gallium(III) (1989) (62)
In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands (2002) (62)
Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. (1994) (62)
Radiometal-labeled agents (non-technetium) for diagnostic imaging. (1999) (61)
External assessment of myocardial metabolism with [11C]palmitate in rabbit hearts. (1979) (61)
Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin (2007) (61)
Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. (2002) (61)
Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. (1995) (60)
Positron-emitting isotopes produced on biomedical cyclotrons. (2005) (59)
Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. (2006) (59)
Characterization of a new certified reference material for human cardiac troponin I. (2006) (58)
MPTP‐induced up‐regulation of in vivo dopaminergic radioligand‐receptor binding in humans (1987) (58)
Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo. (2000) (58)
Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia (2001) (58)
Carbon-11 labeled σ2 receptor ligands for imaging breast cancer (2005) (58)
[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. (2009) (58)
16 alpha-[77Br]bromoestradiol: dosimetry and preliminary clinical studies. (1982) (58)
Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose. (2003) (58)
16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. (1993) (57)
Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives. (1986) (57)
Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry (2007) (57)
A remote system for the routine production of oxygen‐15 radiopharmaceuticals (1985) (57)
Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product. (1994) (57)
Tracer studies with radioactive oxygen-15. Exchange between carbon dioxide and water (1969) (57)
Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. (1995) (56)
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. (2000) (56)
21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography. (1988) (56)
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution. (1995) (56)
MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids. (2005) (56)
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG. (2003) (56)
MicroPET imaging with non-conventional isotopes (2001) (56)
Luminescence imaging using radionuclides: a potential application in molecular imaging. (2011) (55)
Preparation of fluorine-18 aryl fluorides: piperidyl triazenes as a source of diazonium salts (1979) (55)
Gallium-68 1,1,1-tris (5-methoxysalicylaldiminomethyl) ethane: a potential tracer for evaluation of regional myocardial blood flow. (1985) (55)
MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model. (2002) (55)
A semi-automated system for the routine production of copper-64. (2012) (54)
Stability and Structure of Activated Macrocycles. Ligands with Biological Applications. (1996) (54)
Replacement of the carboxylic acid function with fluorine (1986) (54)
Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs. (1994) (54)
Simultaneous quantification of homocysteine and folate in human serum or plasma using liquid chromatography/tandem mass spectrometry. (2005) (54)
Application of microwave technology to the synthesis of short-lived radiopharmaceuticals (1987) (53)
Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma. (2011) (53)
Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. (1996) (53)
Molecular Imaging of Atherosclerotic Plaque with 64Cu-Labeled Natriuretic Peptide and PET (2010) (52)
The Gallium(III) and Indium(III) Complexes of Tris(2-mercaptobenzyl)amine and Tris(2-hydroxybenzyl)amine (1998) (52)
Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. (1993) (52)
Characterization of the uptake of 16α-([18F]fluoro)-17β-estradiol in DMBA-induced mammary tumors (1987) (51)
A synthesis of 7α-substituted estradiols: synthesis and biological evaluation of a 7α-pentyl-substituted BODIPY fluorescent conjugate and a fluorine-18-labeled 7α-pentylestradiol analog (1993) (51)
Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide. (1999) (50)
Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. (1995) (50)
Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy. (1984) (50)
Quantitative determination of capsaicinoids by liquid chromatography–electrospray mass spectrometry (2005) (50)
Platelet Deposition on Vascular Grafts: The Accuracy of in Vivo Quantitation and the Significance of in Vivo Platelet Reactivity (1986) (50)
Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma. (2010) (50)
In vivo comparison of 16 alpha[77Br]bromoestradiol-17 beta and 16 alpha-[125I]iodoestradiol-17 beta. (1982) (50)
In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna. (2006) (50)
11C-Acetate PET imaging for renal cell carcinoma (2009) (49)
Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography. (1991) (49)
Studies of radioiodinated fibrinogen. II. Lactoperoxidase iodination of fibrinogen and model compounds. (1974) (49)
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. (1990) (48)
The synthesis of 7α-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents (1994) (48)
Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate. (1994) (48)
Handbook of radiopharmaceuticals. Radiochemistry and applications (2003) (48)
Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes. (2000) (48)
Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. (2009) (48)
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC? (2012) (47)
Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta. (1986) (47)
Stabilities of trivalent metal complexes of phenolic ligands related to N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) (1990) (47)
N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. (1988) (47)
Labeling of Polymer Nanostructures for Medical Imaging: Importance of crosslinking extent, spacer length, and charge density. (2007) (47)
Indium‐111 platelet scintigraphy in cerebrovascular disease (1982) (45)
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. (1991) (45)
Development of a new standard reference material: SRM 1955 (homocysteine and folate in human serum) (2006) (45)
Two new standard reference materials for the determination of drugs of abuse in human hair (2003) (45)
Metabolic imaging with gallium-68- and indium-111-labeled low-density lipoprotein. (1991) (45)
Characterization of bromine-77-labeled proteins prepared using bromoperoxidase. (1980) (45)
Automatic synthesis of 16α-[18F]fluoro-17β-estradiol using a cassette-type [18F]fluorodeoxyglucose synthesizer (2006) (45)
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. (2007) (44)
Hierarchically assembled theranostic nanostructures for siRNA delivery and imaging applications. (2012) (44)
Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. (2006) (44)
Synthesis of 2-[18F]Fluoroestradiol, a Potential Diagnostic Imaging Agent for Breast Cancer: Strategies to Achieve Nucleophilic Substitution of an Electron-Rich Aromatic Ring with [18F]F- (1999) (43)
Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography. (2010) (43)
Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis. (2005) (43)
A general method for labeling proteins with 11C. (1975) (43)
Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase. (2009) (43)
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. (2009) (43)
A comparison of results for cholesterol in human serum obtained by the Reference Method and by the Definitive Method of the National Reference System for cholesterol. (1990) (42)
Indium-111-labeled human platelets: uptake and loss of label and in vitro function of labeled platelets. (1978) (42)
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. (2006) (42)
Evaluation of myocardial metabolism and perfusion with positron-emitting radionuclides. (1977) (42)
Scintigraphic diagnosis of experimental pulmonary embolism with In-111-labeled platelets. (1977) (42)
Remote system for production of carbon‐11 labeled palmitic acid (1983) (42)
Scintigraphy with 111In-labeled autologous platelets in venous thromboembolism. (1980) (41)
Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution. (2004) (41)
N 3 fluorine 18 fluoropropylspiperone the preferred fluorine 18 labeled spiperone analog for positron emission tomographic studies of the dopamine receptor (1988) (41)
Synthesis and evaluation of [18F] labeled benzamides: high affinity sigma receptor ligands for PET imaging. (1997) (41)
Interlaboratory comparison studies on the analysis of hair for drugs of abuse. (1993) (41)
Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens. (1983) (41)
20-[18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: synthesis and tissue distribution studies. (1991) (41)
Tricatecholamide analogs of enterobactin as gallium- and indium-binding radiopharmaceuticals. (1981) (41)
Comparison of 68Ge/68Ga generator systems for radiopharmaceutical production (1984) (41)
Rapid and reproducible radiosynthesis of [18F] FHBG. (2004) (40)
Enzymatic synthesis of nitrogen-13 labeled amino acids. (1973) (40)
Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. (1995) (40)
Determination of serum uric acid by isotope dilution mass spectrometry as a new candidate definitive method. (1990) (40)
Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. (2009) (39)
Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. (1987) (39)
Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors (2016) (39)
Preparation and preliminary biodistribution of no carrier added fluorine-18 fluoroethanol (1980) (39)
Noninvasive detection of coronary thrombi with In-111 platelets: concise communication. (1983) (38)
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging. (2002) (38)
In Vivo Kinetics of [18F](N-Methyl)Benperidol: A Novel PET Tracer for Assessment of Dopaminergic D2-Like Receptor Binding (1997) (38)
N,N'-Ethylenedi-L-cysteine (EC) and Its Metal Complexes: Synthesis, Characterization, Crystal Structures, and Equilibrium Constants. (1996) (38)
Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents. (1992) (38)
Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH. (2005) (38)
Capillary liquid chromatography/electrospray mass spectrometry for the separation and detection of catechins in green tea and human plasma. (1997) (38)
Improved Methods for the Synthesis of [?- 11 C]Palmitic Acid (1998) (38)
Role of radionuclide imaging in trials of antiangiogenic therapy. (2000) (37)
Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors. (1993) (37)
Evaluation of gallium-68 tris(2-mercaptobenzyl)amine: a complex with brain and myocardial uptake. (1999) (37)
7alpha- and 17alpha-substituted estrogens containing tridentate tricarbonyl rhenium/technetium complexes: synthesis of estrogen receptor imaging agents and evaluation using microPET with technetium-94m. (2003) (36)
THE DISTRIBUTION OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS, QUINUCLIDINYL BENZILATE AND QUINUCLIDINYL BENZILATE METHIODIDE (BOTH TRITIATED), IN RAT, GUINEA PIG, AND RABBIT (1979) (36)
Comparative breast tumor imaging and comparative in vitro metabolism of 16α-[18F]Fluoroestradiol-17β and 16β-[18f]fluoromoxestrol in isolated hepatocytes (1999) (36)
Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models. (1977) (36)
Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. (2004) (36)
Scintigraphic detection of platelet deposition in atherosclerotic macaques: a new technique for investigation of antithrombotic drugs. (1982) (36)
Unsatisfactory biologic behavior of I-fibrinogen labeled by the chloramine-T method. (1973) (36)
Molecular imaging: The application of small animal positron emission tomography (2002) (36)
Preparation of millicurie quantities of oxygen‐15 labeled water (1969) (36)
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging. (2007) (35)
16β-[18F]fluoromoxestrol : a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors (1993) (35)
No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues. (1989) (35)
Synthesis and In Vivo Evaluation of 2 High-Affinity 76Br-Labeled σ2-Receptor Ligands (2006) (35)
Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis. (2004) (35)
Halofluorination of olefins: elucidation of reaction characteristics and applications in labeling with the positron-emitting radionuclide fluorine-18 (1986) (34)
Investigation of copper-PTSM as a PET tracer for tumor blood flow. (1991) (34)
PET Imaging of Chemokine Receptors in Vascular Injury–Accelerated Atherosclerosis (2013) (34)
Imaging of the inflammatory response in ischemic canine myocardium with 111indium-labeled leukocytes. (1977) (34)
Techniques necessary for multiple tracer quantitative small-animal imaging studies. (2005) (34)
Hybrid image and blood sampling input function for quantification of small animal dynamic PET data. (2007) (34)
Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors. (2005) (33)
Stability of metal ion complexes of 1,4,7-tris(2-mercaptoethyl)-1,4,7-triazacylclonane (TACN-TM) and molecular structure of In(C12H24N3S3) (1995) (33)
Positron emission tomography measurements of pulmonary vascular permeability with Ga-68 transferrin or C-11 methylalbumin. (1998) (33)
Elimination of contaminant Kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-2-deoxy-D-glucose. (1989) (33)
Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes. (2000) (33)
Comparison of isotope dilution mass spectrometry methods for the determination of total homocysteine in plasma and serum. (2003) (33)
PEGylation of cationic, shell-crosslinked-knedel-like nanoparticles modulates inflammation and enhances cellular uptake in the lung. (2013) (33)
Fluorine-18-labeled diethylaminosulfur trifluoride (DAST): an F-for-OH fluorinating agent. (1977) (33)
Preparation and value assignment of standard reference material 968e fat-soluble vitamins, carotenoids, and cholesterol in human serum (2011) (32)
Blueprint for imaging in biomedical research. (2007) (32)
Radiolabeling of platelets. (1984) (32)
Heterogeneity in human cardiac troponin I standards. (2000) (31)
Highly iodinated fibrinogen: a new thrombus-localizing agent. (1975) (31)
N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies. (1995) (31)
N,N'-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2 -ethylenediamine-N,N'-diacetic acid: a new bifunctional chelate for radiolabeling antibodies. (1990) (31)
Targeting radiopharmaceuticals: comparative biodistribution studies of gallium and indium complexes of multidentate ligands. (1988) (31)
The application of maximum likelihood factor analysis (MLFA) with uniqueness constraints on dynamic cardiac microPET data (2007) (31)
Imaging Multidrug Resistance P-glycoprotein Transport Function Using MicroPET with Technetium-94m-Sestamibi (2005) (30)
Synthesis, radiolabeling and tissue distribution of 11 beta-fluoroalkyl- and 11 beta-fluoroalkoxy-substituted estrogens: target tissue uptake selectivity and defluorination of a homologous series of fluorine-18-labeled estrogens. (1993) (30)
(2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo. (1983) (29)
In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in Rodents: Differential Efficacy of Metformin and Rosiglitazone Monotherapy (2009) (29)
Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot. (1988) (29)
Reversed-phase liquid chromatography and argentation chromatography of the minor capsaicinoids (2005) (29)
Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. (2004) (28)
Robotic production of 2-deoxy-2-[18F]fluoro-D-glucose: a routine method of synthesis using tetrabutylammonium [18F]fluoride. (1988) (28)
Synthesis and crystallographic characterization of a gallium salicylaldimine complex of radiopharmaceutical interest (1984) (28)
An in vivo evaluation of I-fibrinogen labeled by four different methods. (1974) (28)
Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents. (2009) (28)
Production, processing and small animal PET imaging of titanium-45. (2005) (28)
FORMATION OF PHENYLPIPERAZINES BY A NOVEL ALUMINA SUPPORTED BIS-ALKYLATION (1996) (28)
Antibody fragments labeled with fluorine-18 and gallium-68: in vivo comparison with indium-111 and iodine-125-labeled fragments. (1991) (27)
Advances in the production, processing and microPET image quality of technetium-94m. (2006) (27)
Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers. (1996) (27)
Organ uptake and blood pH and concentration effects of ammonia in dogs determined with ammonia labeled with 10 minute half‐lived nitrogen 13 (1973) (27)
In vitro stability and in vivo clearance of fibrinogen or serum albumin labeled with 77Br, 131I, or 125I by direct or indirect synthetic methods. (1977) (27)
PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins. (1998) (27)
Characterization of Nontransmural Myocardial Infarction by Positron‐emission Tomography (1982) (27)
Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer. (2005) (27)
Fibrinogen uptake by thrombi: effect of thrombus age. (1975) (26)
Positron emission tomography shows that intrathecal leptin reaches the hypothalamus in baboons. (2002) (26)
Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide. (2006) (26)
New window flow proportional counter for counting radioactive gas-liquid partition chromatography effluents (1967) (26)
Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol. (2005) (26)
The liquid chromatographic purification of carbon-11 labeled glucose. (1973) (26)
Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity. (2005) (26)
Sites of direct and indirect halogenation of albumin. (1978) (26)
Isotope dilution mass spectrometry as a candidate definitive method for determining total glycerides and triglycerides in serum. (1995) (25)
Molecular Mechanics Investigation of Gadolinium(III) Complexes. (1996) (25)
On the difference between using linear and non‐linear models in bracketing procedures in isotope dilution mass spectrometry (1983) (24)
Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors. (1986) (24)
In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. (2004) (24)
Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. (1993) (23)
The Reactions of Recoil 18N Atoms with some Organic Compounds in the Solid and Liquid Phases (1973) (23)
Effects of Chelator Modifications on 68Ga-Labeled [Tyr3]Octreotide Conjugates (2013) (23)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXVII. 73Se (1978) (23)
Validation of the dual radiotracer method for quantitative In-111 platelet scintigraphy. (1984) (23)
Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. (2000) (23)
Synthesis and tissue biodistribution of [omega-11C]palmitic acid. A novel PET imaging agent for cardiac fatty acid metabolism. (1994) (23)
In vivo measurements of pulmonary angiotensin-converting enzyme kinetics. II. Implementation and application. (1995) (23)
Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity. (2006) (23)
Radioiodinated plasminogen: an imaging agent for pre-existing thrombi. (1977) (23)
Synthesis of DL-[3-11C]phenylalanine. (1984) (22)
Cost analyses of positron emission tomography for clinical use. (1983) (22)
The determination of amphetamine and methamphetamine in a lyophilized human urine reference material. (1993) (22)
External quantification of myocardial perfusion by exponential infusion of positron-emitting radionuclides. (1980) (22)
(2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo. (1982) (22)
Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target. (2012) (22)
New chelating agents suitable for the treatment of iron overload (1999) (22)
Nucleic Acid-directed Self-assembly of Multifunctional Gold Nanoparticle Imaging Agents. (2013) (22)
Regioselective N-substitution of cyclen with two different alkyl groups: synthesis of all possible isomers. (2003) (22)
N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography. (1990) (21)
Determination of serum urea by isotope dilution mass spectrometry as a candidate definitive method. (1984) (21)
N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride. (1990) (21)
Target tissue uptake selectivity of three fluorine-substituted progestins: potential imaging agents for receptor-positive breast tumors. (1990) (21)
Long-term evaluation of TiO2-based 68Ge/68Ga generators and optimized automation of [68Ga]DOTATOC radiosynthesis. (2012) (21)
Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction. (1984) (21)
An Imaging Comparison of 64 Cu-ATSM and 60 Cu-ATSM in Cancer of the Uterine Cervix (2008) (21)
18 F-Fluoroacetate : A Potential Acetate Analog for Prostate Tumor Imaging — In Vivo Evaluation of 18 F-Fluoroacetate Versus 11 C-Acetate (2007) (21)
Development of a model system to evaluate methods for radiolabeling monoclonal antibodies. (1984) (21)
Fluorine-18 labeled receptor based radiopharmaceuticals. (1986) (21)
Robotic preparation of Sodium Acetate C 11 Injection for use in clinical PET. (2002) (20)
Automatic synthesis of 16 alpha-[(18)F]fluoro-17beta-estradiol using a cassette-type [(18)F]fluorodeoxyglucose synthesizer. (2006) (20)
Radioiodinated Soluble Canine Fibrin: PREPARATION AND EVALUATION AS A THROMBUS LOCALIZING AGENT IN THE DOG (1975) (20)
Carbon-11-labeled estrogens as potential imaging agents for breast tumors. (1996) (20)
Highly efficient click labeling using 2-[¹⁸F]fluoroethyl azide and synthesis of an ¹⁸FN-hydroxysuccinimide ester as conjugation agent. (2012) (20)
Positron Emission Tomography Imaging of Hypoxia. (2009) (20)
The reactivity of thermal carbon atoms in the gas phase (1968) (20)
Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning (2006) (20)
No-carrier-added synthesis of [1-11C]pyruvic acid. (1982) (20)
Radiopharmaceuticals and other compounds labelled with short-lived radionuclides (1977) (20)
New approach to fully automated synthesis of sodium [18F]fluoroacetate -- a simple and fast method using a commercial synthesizer. (2006) (20)
Application of microwave heating to the synthesis of [18F]fluoromisonidazole. (1993) (20)
Improved synthesis of 1-[11C]D-glucose. (1993) (19)
Effect of iodination level on the properties of radioiodinated fibrinogen. (1975) (19)
Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline. (1997) (19)
QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties. (2005) (19)
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. (2008) (19)
Synthesis and evaluation of a bromine-76-labeled PPARgamma antagonist 2-bromo-5-nitro-N-phenylbenzamide. (2006) (19)
The state of positron emitting radionuclide production in 1997. (1998) (19)
The potential role of generator-produced radiopharmaceuticals in clinical PET. (2000) (19)
A new bifunctional chelate, BrMe2HBED : an effective conjugate for radiometals and antibodies (1990) (19)
Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models (2010) (19)
Use of tricatecholamide ligands to alter the biodistribution of gallium-67: concise communication. (1982) (19)
Imaging myocardium enzymatic pathways with carbon-11 radiotracers. (2004) (19)
Comparison by LC-MS and MALDI-MS of prostate-specific antigen from five commercial sources with certified reference material 613. (2005) (19)
SYNTHESES OF MULTIDENTATE LIGANDS CONTAINING HYDROXYPRYIDYL DONOR GROUPS (1991) (18)
Fluorine-substituted corticosteroids: synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain. (1992) (18)
FATE OF $sup 13$N FORMED BY THE $sup 12$C(d,n)$sup 13$N REACTION IN INORGANIC CARBIDES. (1971) (18)
In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent. (1976) (18)
Positron Emission Reconstruction Tomography For The Assessment Of Regional Myocardial Metabolism By The Administration Of Substrates Labeled With Cyclotron Produced Radionuclides (1976) (18)
Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field. (2001) (18)
Modifications to the NIST reference measurement procedure (RMP) for the determination of serum glucose by isotope dilution gas chromatography/mass spectrometry (2010) (18)
Electrospray ionization mass spectrometry for the quantitation of albumin in human serum (1997) (17)
A remote system for the synthesis of copper-62 labeled Cu(PTSM). (1991) (17)
Scintigraphic detection of an arterial thrombus with In-111-labeled autologous platelets. (1980) (17)
Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report. (2008) (17)
Synthesis, characterization, and Cu(II) solution chemistry of dioxotetraazamacrocycles (1999) (17)
Enzymatic syntheses of 6-(4H-selenolo[3,2-b]pyrrolyl)-L-alanine, 4-(6H-selenolo[2,3-b]pyrrolyl)-L-alanine, and 6-(4H-furo[3,2-b]pyrrolyl-L-alanine. (1999) (17)
In vivo measurements of pulmonary angiotensin-converting enzyme kinetics. I. Theory and error analysis. (1995) (17)
Microwave‐facilitated synthesis of [18F]‐spiperone (1989) (17)
N,N′,N″-tris(3-hydroxy-6-methyl-2-pyridylmethyl)-1,4,7-triazacyclonana, a new effective ligand for iron (III) (1990) (17)
Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides. (2007) (17)
N-3-[18F]fluoropropylputrescine as potential PET imaging agent for prostate and prostate derived tumors. (1989) (17)
Investigation of physicochemical and in-vivo behavior of diastereomeric iron-59, gallium-68, and indium-111-EHPG trivalent metal complexes. (1990) (17)
Positron labeled muscarinic acetylcholine receptor antagonist: 2- and 4-[18F]fluorodexetimide. Syntheses and biodistribution. (1991) (17)
Development and evaluation of a reference measurement procedure for the determination of estradiol-17beta in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. (2005) (16)
Evaluation of the stability and animal biodistribution of gadolinium (III) benzylamine-derivatized diethylenetriaminepentaacetic acid. (1996) (16)
Sex-dependent differences in N-(3-[18F]fluoropropyl)-N-nordiprenorphine biodistribution and metabolism. (1990) (16)
Certification of phencyclidine in lyophilized human urine reference materials. (1996) (16)
Comparison of animal models for the evaluation of radiolabeled androgens. (2001) (16)
Interlaboratory studies on the analysis of hair for drugs of abuse: results from the fourth exercise. (1996) (16)
Stabilities of gallium(III), iron(III), and indium(III) chelates of hydroxyaromatic ligands with different overall charges (1991) (16)
Preparation of Alkyl and Aryl Chlorodifluoromethyl Ethers Using BrF3 (2008) (16)
16β-((18F)Fluoro)estrogens: Systematic Investigation of a New Series of Fluorine-18-Labeled Estrogens as Potential Imaging Agents for Estrogen-Receptor-Positive Breast Tumors. (1993) (16)
A new procedure for labeling alkylbenzenes with [18F]fluoride. (1991) (15)
Exhaled nitric oxide correlates with experimental lung transplant rejection. (2000) (15)
Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes. (1999) (15)
Radiobromine for Imaging and Therapy (2005) (15)
Methodologic and basic aspects of indium-111 platelets. (1983) (15)
Evaluation of radiolabeled type IV collagen fragments as potential tumor imaging agents. (2001) (15)
Synthesis, biological evaluation, and baboon PET imaging of the potential adrenal imaging agent cholesteryl-p-[18F]fluorobenzoate. (1999) (15)
Synthesis of carbon-11 labelled amides via carbonylation of lithium dialkylamides (1983) (15)
Comparison of 111In-oxine and 111In-acetylacetone for the labeling of cells: in vivo and in vitro biological testing. (1981) (15)
Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine. (1990) (15)
Positron tomographic imaging of the liver: 68 Ga iron hydroxide colloid. (1981) (15)
Biomedical imaging research opportunities workshop IV: a white paper. (2007) (14)
Preparation and in vitro properties of 99mTc-fibrinogen. (1976) (14)
Re: Terminology Concerning Specific Activity of Radiopharmaceuticals—Reply (1981) (14)
Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide. (2006) (14)
Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. (1997) (14)
Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents. (1994) (14)
64Cu-labeled CB-TE2A and Sar conjugated RGD peptide analogs for targeting angiogenesis: Comparison of their biological activity (2007) (14)
Improved Syntheses of [3,2-b]- and [2,3-b]-fused Selenolo- and Thienopyrroles, and of Furo[3,2-b]pyrrole (1999) (13)
Automated production of oxygen-15 labeled butanol for PET measurement of regional cerebral blood flow. (1993) (13)
Evidence for a saturable clearance mechanism for 111In-labeled monoclonal antibodies. (1985) (13)
Comparative studies using 125I- and 111In-labeled monoclonal antibodies. (1986) (13)
LOCALIZATION OF VIABLE, ISCHEMIC MYOCARDIUM BY POSITRON-EMISSION TOMOGRAPHY WITH 11C-PALMITATE (1982) (13)
Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET. (2009) (13)
Molecular Mechanics Force Field for Modeling Technetium(V) Complexes. (1996) (13)
Estrogen platinum-diamine complexes: Preparation of a non-steroidal estrogen platinum—diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo (1992) (13)
Synthesis of new multidentate ligands for the coordination of indium(iii), gadolinium(iii) and thorium(iv) (1991) (13)
Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor. (2007) (13)
16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors. (1981) (13)
The certification of morphine and codeine in a human urine standard reference material. (1994) (13)
Antisense peptide nucleic acid-functionalized cationic nanocomplex for in vivo mRNA detection (2013) (13)
Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors. (1987) (13)
Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging. (1990) (13)
2-[18F]fluoroputrescine: preparation, biodistribution, and mechanism of defluorination. (1986) (13)
Application of a novel phenylpiperazine formation reaction to the radiosynthesis of a model fluorine-18-labeled radiopharmaceutical (18FTFMPP). (1997) (13)
Synthesis and in vitro characterization of fluorinated U-50488 analogs for PET studies of kappa opioid receptors. (1990) (13)
A new approach for the synthesis of [11C]‐labeled fatty acids (2000) (13)
Measurement of upregulation of inducible nitric oxide synthase in the experimental autoimmune encephalomyelitis model using a positron emitting radiopharmaceutical. (1997) (13)
Synthesis of 18F-labeled 6- and 7-fluoropalmitic acids. (1983) (13)
Erratum: Preparation and evaluation of 17-ethynyl-substituted 16α-[18F]fluoroestradiols: selective receptor-based PET imaging agents (Nuclear Medicine and Biology - International Journal of Radiation Applications and instrumentation Part B (Vol.nr. 19) (363-374)) (1992) (12)
Partitioning of kinetic energy to internal energy in the low energy collision-induced dissociations of proton-bound dimers of polypeptides (1999) (12)
Methods to label monoclonal antibodies for use in tumor imaging. (1987) (12)
Bromination from the macroscopic level to the tracer radiochemical level: (76)Br radiolabeling of aromatic compounds via electrophilic substitution. (2009) (12)
Comparison of bromo- and iodoalkyl triflates for 18F-radiolabeling of amines. (1990) (12)
Improved synthesis of [18F]4-fluorophenacyl bromide: the use of polymer supported perbromide. (1993) (12)
Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands. (2006) (12)
Characterization of 64Cu-DOTA-Conatumumab: A PET Tracer for In Vivo Imaging of Death Receptor 5 (2011) (12)
Synthesis and uptake of no-carrier-added 1-[11C]putrescine into rat prostate. (1985) (12)
Small molecule receptors as imaging targets. (2008) (12)
Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver. (1998) (12)
β-Cyclodextrin dimers as potential tumor pretargeting agents (2001) (12)
Evaluation of two new gadolinium chelates as contrast agents for MRI. (1992) (12)
Labeling with iodine-123. The reactivity of iodine-123 formed by the decay of xenon-123. (1970) (12)
The certification of cocaine and benzoylecgonine in a human urine standard reference material. (1992) (12)
Preparation and use of 123I-labeled highly iodinated fibrinogen for imaging deep-vein thrombi. (1976) (12)
Steroid Hormone Receptors as Targets for Diagnostic Imaging (1996) (12)
Reactivity of p-[18F]fluorophenacyl bromide for radiolabeling of proteins and peptides. (1997) (12)
Accuracy of participant results utilized as target values in the CAP Chemistry Survey Program. (1985) (12)
Clinical chemistry of the tin-indium generator. (1969) (11)
No-carrier-added radiobromination via cuprous chloride-assisted nucleophilic aromatic bromodeiodination. (1988) (11)
Imaging of canine tumors with 11C-methylputrescine. (1978) (11)
Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand. (1995) (11)
New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III). (1995) (11)
The stability of uric acid in ammonium hydroxide. (1988) (11)
Human parathyroid antigen: characterization and localization with monoclonal antibodies. (1986) (11)
Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F] propyl pyrazole triol. (2003) (11)
ISOTOPE PRODUCTION WITH BREMSSTRAHLUNG BEAMS IN COMPARISON WITH PROTON BEAMS (1980) (11)
N,N′-bis(2-mercaptoethyl)ethylenediamine-N,N′-diacetic acid; an effective ligand for indium(III) (1995) (11)
Metabolism in vitro of radioiodinated N-isopropyl-p-iodoamphetamine by isolated hepatocytes. (1993) (11)
Radionuclide imaging of dog prostate. (1978) (10)
Biomedical Imaging Research Opportunities Workshop: report and recommendations. (2003) (10)
Conventional and induction furnace distillation procedures for the routine production Br‐76, 77 and I‐124 on disk and slanted targets (2001) (10)
Evaluation of two new bifunctional chelates for radiolabeling a parathyroid-specific monoclonal antibody with In-111. (1991) (10)
Metal Radionuclides for PET Imaging (2005) (10)
Production, processing and uses of 94mTc (2001) (10)
New multidentate ligands containing mercaptobenzyl functional groups, and biodistribution of gallium-67-TACN-HSB (1999) (10)
Evaluation of PLED as a chelating ligand in the preparation of gallium and indium radiopharmaceuticals. (1985) (10)
Fluorine-substituted ligands for the peroxisome proliferator-activated receptor gamma (PPARgamma): potential imaging agents for metastatic tumors. (2001) (10)
Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer (1994) (10)
6α-[18F]Fluoroprogesterone: Synthesis via halofluorination-oxidation, receptor binding and tissue distribution (1995) (10)
Intramolecular Effects of 125 I Decay in o-Iodotyrosine (1980) (10)
Photodissociation of the molecular ion of n-butylbenzene: effect of photon energy (1985) (10)
Potential Labeling of Monoclonal Antibodies with Positron Emitters (1986) (9)
Scope and limitations of a rapid radiobromination technique (1981) (9)
Two novel macrocyclic monooxo-tetraamines and the stabilities of their Cu(II) complexes (2002) (9)
Evaluation of the in vitro stability of gadolinium (III) polyoxometalates. (1997) (9)
Remote system for production of carbon‐11 labeled glucose via photosynthesis (1984) (9)
[Tc(CO)3]+ chemistry: a promising new concept for SPECT? (2003) (9)
Perturbed angular correlation studies of 111In-labelled platelets. (1982) (9)
CCQM-K12: The determination of creatinine in serum (2003) (9)
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35years of the ISRC? (2013) (9)
Synthesis and evaluation of 18F-labeled PPARγ antagonists. (2012) (9)
Synthesis and tissue distribution of fluorine-18 labeled trifluorohexadecanoic acids. Considerations in the development of metabolically blocked myocardial imaging agents. (1990) (9)
Synthesis and characterization of two novel macrocyclic monoxo-tetraamines and the stabilities of their Cu(II) complexes (2001) (9)
Investigations into tumor accumulation and peroxisome proliferator activated receptor binding by F-18 and C-11 fatty acids. (2002) (9)
Binding of 16α-[18F]Fluoro-17β-estradiol to alphafetoprotein in Sprague-Dawley female rats affects blood levels (1990) (9)
Radiolabeled Compounds of Biomedical Interest Containing Radioisotopes of Gallium and Indium (1980) (9)
Inhaled [13N]nitric oxide: a positron emission tomography (PET) study. (1996) (9)
Synthesis of a New Diaminodithiol Bifunctional Chelator for Radiolabeling Biomolecules with Indium(III) (2000) (9)
SEP-PAK Preparative Chromatography: Use in Radiopharmaceutical Synthesis (1982) (8)
NMR ENHANCEMENT WITH Gd LABELED ANTIBODIES (1988) (8)
Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-α receptors. (2012) (8)
[18F]spiroperidol: A radiopharmaceutical for the in vivo study of the dopamine receptor (1984) (8)
Bromo[18F]fluorination of cyclohexenes: a method for the preparation of [18F]fluorocyclohexanes (1995) (8)
Radiosynthesis of N‐(ω‐[18F]fluoroalkyl) derivatives of the dopaminergic receptor‐binding ligand raclopride (1989) (8)
A windowless 13N production target for use with low energy deuteron accelerators. (1994) (8)
Synthesis, estrogen receptor binding, and tissue distribution of [18F]fluorodoisynolic acids. (1997) (8)
A Potential Dubin-Johnson Syndrome Imaging Agent: Synthesis, Biodistribution, and MicroPET Imaging (2005) (8)
ABSOLUTE CROSS SECTIONS FOR THE PRODUCTION OF 18F VIA THE 18O(p,n) 18F REACTION (1980) (8)
FORMATION OF EXCITED INTERMEDIATES IN RECOIL CARBON ATOM REACTIONS. PRESSURE-DEPENDENCE STUDIES IN THE GAS PHASE. (1969) (8)
68GaTHM2BED: a potential generator-produced tracer of myocardial perfusion for positron emission tomography. (1992) (7)
Radionuclides of Bromine for Use in Biomedical Studies (1983) (7)
In vivo measurement of cerebral glucose metabolism employing 11C-labeled glucose. (1973) (7)
Production of [13N]ammonia applicable to low energy accelerators. (1994) (7)
123I-labeled soluble fibrin: preparation and comparison with other thrombus imaging agents. (1977) (7)
STABILITIES OF SOME TRIVALENT AND DIVALENT METAL ION COMPLEXES OF N,N′-BIS(2-MERCAPTOETHYL)ETHYLENEDIAMINE-N,N′-DIACETIC ACID, AN EFFECTIVE LIGAND FOR INDIUM(III) (1995) (7)
A potential new radiopharmaceutical for parathyroid imaging: radiolabeled parathyroid-specific monoclonal antibody--II. Comparison of 125I- and 111In-labeled antibodies. (1988) (7)
Regional cerebral oxygen utilization with positron emission tomography. (1979) (7)
Development of a positron emitting radio pharmaceutical suitable for imaging myelin (1982) (7)
Evaluation of a RGD-dendrimer labeled with 76Br in hindlimb ischemia mouse model (2008) (7)
7α-18F-Fluoromethyl-Dihydrotestosterone and 7α-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone–Binding Globulin for Steroidal Radiopharmaceuticals (2008) (7)
Three-dimensional in vivo mapping of brain metabolism and acid-base status. (1977) (7)
Comparison of Ge-68/Ga-68 generator systems for radiopharmaceutical production (1982) (7)
Comparison of two bifunctional chelates for labeling 64Cu to Mab 1A3 and 1A3-F(ab')2: Chemistry and animal biodistribution (1994) (7)
Effect of administration route on FES uptake into MCF-7 tumors. (2001) (7)
Production of 1‐11C‐acetoacetic acid (1974) (7)
Radiosynthesis of (N-[11C]methyl)benperidol for PET investigation of D2 receptor binding (2004) (7)
Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody. (1994) (7)
Photodissociation of ions generated by soft ionization techniques (1986) (7)
CCQM-K11: The determination of glucose in serum (2003) (7)
Radiochemical Synthesis, Rodent Biodistribution and Tumor Uptake, and Dosimetry Calculations of [11C] Methylated LY2181308 (2010) (7)
NIST reference materials to support accuracy in drug testing (1995) (6)
Chemistry of recoil tritium atoms. Part 1.—Reaction with n-butane, n-pentane and neo-pentane (1968) (6)
SYNTHESIS AND STABILITIES OF THE GA(III) AND IN(III) CHELATES OF A NEW DIAMINODITHIOL BIFUNCTIONAL LIGAND (1998) (6)
Characterization of Spillover and Recovery Coefficients in the Gated Mouse Heart for Non-Invasive Extraction of Input Function in microPET Studies: Feasibility and Sensitivity Analysis (2006) (6)
Development and evaluation of a rapid and efficient electrolytic preparation of 99mTc-labeled red blood cells. (1977) (6)
Reactions of recoil iodine formed by the xenon-125 .far. iodine-123 system with simple hydrocarbons. II. Pressure studies on the methane and ethane systems (1973) (6)
Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes. (1994) (6)
Synthesis of difluoroaryldioxoles using BrF3. (2011) (6)
Synthesis of 2-[(18)F]Fluoroestradiol, a Potential Diagnostic Imaging Agent for Breast Cancer: Strategies to Achieve Nucleophilic Substitution of an Electron-Rich Aromatic Ring with [(18)F]F(-). (1999) (6)
THE PREPARATION OF PERMANGANATE-OXIDISED RIBONUCLEIC ACID AND ITS HYDROLYSIS WITH PANCREATIC RIBONUCLEASE. (1965) (6)
Synthesis and characterization of racemic mixture and meso isomers of bis(trans-2-aminocyclohexyl)aminepentaacetic acid and the stabilities of their Gd(III) complexes. (2000) (6)
Transgenic Expression of FATP1 in the Heart Causes Lipotoxic Cardiomyopathy (2004) (6)
Radiopharmaceuticals labeled with short-lived positron-emitting radionuclides. (1985) (6)
External Detection and Visualization of Myocardial Ischemia with x ̂Substrates x ̂Substrates x ̂Substrates in Vitro and in Vivo (2005) (6)
An improved synthesis of no‐carrier‐added 3‐[18F]‐fluoro‐1‐(2‐nitro‐1‐imida‐zolyl‐2‐propanol (1989) (5)
Intratumoral Heterogeneity of 64Cu-ATSM Uptake is a Prognostic Indicatorin Patients with Cervical Cancer (2013) (5)
Intramolecular effects of radioiodine decay in o-iodophenol, a model for radioiodinated proteins. (1975) (5)
Radiochemistry and radiopharmaceuticals (2006) (5)
Studies on the no-carrier-added synthesis and chemistry of 11C labelled methyl hypofluorite (1993) (5)
Targeting radiopharmaceuticals--II. Evaluation of new trivalent metal complexes with different overall charges. (1991) (5)
CCQM-K6: Key Comparison on the Determination of Cholesterol In Serum* Final Report December 2001 (2001) (5)
A potential new radiopharmaceutical for parathyroid imaging: radiolabeled parathyroid-specific monoclonal antibody--I. Evaluation of 125I-labeled antibody in a nude mouse model system. (1988) (5)
Reactions of recoil iodine formed by the $sup 123$Xe $Yields$ $sup 123$I system with simple hydrocarbons. Effects of additives on the reactivity. (1973) (5)
Effect of stereochemistry on the clearance mechanism of 111In(III)-labeled D- or L-benzyldiethylenetriaminepentaacetic acid. (1997) (5)
The Installation of a Solid Target System Produced by Newton Scientific on a 168 JSW Baby Cyclotron Capable of Loading and Delivering Multiple Solid Targets with a Single Setup (2003) (5)
Methyl hypofluorite in the synthesis of 16-methoxyestradiol stereoisomers (1998) (5)
Letter from the guest editors [2] (1998) (5)
USE OF BROMOPEROXIDASE, AN ALGAL ENZYME, IN THE PREPARATION OF RADIOBROMINATED PROTEINS (1979) (5)
Preparation of pure carrier-free 123Xe for rare-gas washout studies. (1973) (5)
An Automatic GLPC Apparatus for the Analysis of Organic Compounds Labeled with Short-Lived Radioisotopes (1969) (5)
Neutral complexes of IN‐111 containing triamine based hexachelating ligands (1989) (5)
Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method. (2004) (5)
The Simultaneous Measure In Vivo of Regional Cerebral Blood Flow and Regional Cerebral Oxygen Utilization by Means of Oxyhemoglobin Labelled with Radioactive Oxygen15 (1969) (5)
Ga-68 labeled DOTA-rhenium cyclized α -MSH analog for imaging of malignant melanoma (2008) (5)
Ion-molecular reactions in methyl halides. Behavior of methyl cations and halide transfer reactions (1974) (5)
An international intercomparison for 19-norandrosterone in human urine: the Comité Consultatif pour la Quantité de Matière (CCQM) Pilot Study CCQM-P68 (2007) (5)
Intramolecular effects of radioiodine decay in 3-lodotyrosine. (1977) (5)
Reactions with aromatic compounds of recoiling bromine atoms formed from the /sup 76/ /sup 77/Kr. -->. /sup 76/ /sup 77/Br transformations. Liquid-phase reactions (1983) (5)
Analysis by a combination of gas chromatography and tandem mass spectrometry: Development of quantitative tandem‐in‐time ion trap mass spectrometry: Isotope dilution quantification of 11‐nor‐delta‐9‐tetrahydrocannabinol‐9‐carboxylic acid (1995) (5)
Preparation and preliminary biodistribution of "no carrier added" fluorine1-8 fluoroethanol. (1980) (5)
A Novel Hexachelating Amino-Thiol Ligand and Its Complex with Gallium(III). (1990) (4)
Molecular Imaging of Vascular Inflammation with Nanoparticles (2010) (4)
A remote system for the routine production of uniformly labeled carbon-11 glucose for metabolism studies (1982) (4)
Application of SPECT to the in vivo measurement of benzodiazepine potency. (1991) (4)
Synthesis of a fluorine-18 labeled hypoxic cell sensitizer (1984) (4)
Production of radioisotopes for biomedical studies using photonuclear reactions (1973) (4)
16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors. (1993) (4)
RESEARCH ARTICLE Effects of Chelator Modifications on 68 Ga-Labeled (Tyr 3 )Octreotide Conjugates (2013) (4)
CHEMISTRY OF RECOIL TRITIUM ATOMS. PART 2. RELATIVE ENERGIES OF HOT ATOM REACTIONS. (1970) (4)
Solid phase synthesis of teta conjugated vasoactive intestinal peptide and in vivo behavior of copper‐64 radiolabeled vip conjugate (2001) (4)
Stabilities of complexes of trivalent metal ions of radiopharmaceuticals with synthetic chelating ligands (1989) (4)
No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-[123I] iodobenzyl)-1,3-propanediamine. (1990) (4)
A simple synthesis of bromine-77-labeled alkyl bromides. (1982) (4)
Role of scavengers in gas-phase recoil tritium reactions (1966) (4)
CYCLOTRON ISOTOPES AND RADIOPHARMACEUTICALS—XXVIII. PRODUCTION OF POTASSIUM‐38 FOR MYOCARDIAL PERFUSION STUDIES (1979) (4)
Certification of drugs of abuse in a human serum standard reference material: SRM 1959 (2010) (4)
Single input multiple output (SIMO) optimization for input function estimation: a simulation study (2007) (4)
Non-standard isotope production and applications at Washington University (2001) (4)
Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals. (1982) (3)
Automated synthesis of 16{beta}-[18F]fluoro-5{alpha}-dihydrotestosterone using a plastic cassette-type FDG synthesizer (2010) (3)
EXCITATION FUNCTIONS FOR THE PRODUCTION OF BROMINE-75: A POTENTIAL NUCLIDE FOR THE LABELING OF RADIOPHARMACEUTICALS (1980) (3)
Long Lived and Unconventional PET Radionuclides (2008) (3)
Reactions of recoil bromine formed by the /sup 76/ /sup 77/Kr. -->. /sup 76/ /sup 77/Kr. -->. /sup 76/ /sup 77/Br systems with simple hydrocarbons. Solid-phase reactions (1981) (3)
A Further Study of Wall-Effects in Gas-Phase Recoil Tritium Chemistry (1966) (3)
A new radiochemical method to determine the stability constants of metal chelates attached to a protein. (1990) (3)
Abstract 5443: A phase 1 evaluation of64Cu-DOTA-patritumab to assess dosimetry, receptor occupancy, and safety in advanced solid tumors (2014) (3)
NIST's role in measurement accuracy for diagnosis and monitoring of diabetes. (2002) (3)
A prospective study on tumor hypoxia kinetics to implement hypoxic imaging-guided IMRT (2001) (3)
Use of O-15 water and C-11 butanol to measure cerebral blood flow (CBF) and water permeability with positron emission tomography (PET) (1985) (3)
A synthesis of 7 alpha-substituted estradiols: synthesis and biological evaluation of a 7 alpha-pentyl-substituted BODIPY fluorescent conjugate and a fluorine-18-labeled 7 alpha-pentylestradiol analog. (1993) (3)
Certification of morphine-3-β-D-glucuronide in a human urine standard reference material (1997) (3)
Fluorine‐18 labeled 11β‐substituted estrogens: Synthesis, receptor binding, and comparative target tissue uptake studies (1989) (3)
Example of imaging solutions to multi-disease biological challenge--imaging of hypoxia. (2003) (3)
27 Radiochemistry and radiopharmaceuticals (2005) (3)
Retardation of 17-oxidation of 16α-[18F]fluoroestradiol-17β by substitution of deuterium for hydrogen in the 17α position(6) (1997) (3)
EXCITATION FUNCTIONS FOR THE PRODUCTION OF 76Kr AND 77Kr (1979) (3)
The use of cultured liver cells from rats and humans to study the metabolism of the pet imaging agent fluorine 18 labeled fluoroestradiol (1991) (3)
TMPHPG: a lipophilic derivative of EHPG for iron, gallium-68 and indium-111 hepatobiliary clearance. (1991) (3)
Syntheses of Multidentate Ligands Containing Hydroxypyridyl Donor Groups. (1991) (3)
Evaluation of a 64Cu-labeled bombesin analogue for diagnosis of gastrin-releasing peptide receptor positive tumors by micropet imaging (2001) (3)
Formation of Phenylpiperazines by a Novel Alumina‐Supported Bis‐ Alkylation. (1996) (3)
The Reactions of Recoil Tritium Atoms with Ethane in the Presence of Various Inert Moderators (1966) (3)
Production of active molecular nitrogen by the reaction of recoil nitrogen-13 (1968) (3)
Positron Tomographic Imaging Of The Liver With Ga-68 Iron Hydroxide Colloid (1980) (2)
Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging. (2012) (2)
Tyramine‐cellobiose (TC) labeling of antibodies: A comparison with other labeling techniques (1989) (2)
Solid phase bovine thrombin. Preparation and properties. (1976) (2)
New Radiopharmaceuticals for studying liver function. (1982) (2)
Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mL. (2013) (2)
NCA 16 alpha-[18F]fluoroestradiol-17 beta: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity. (1986) (2)
Validation of New Instrumentation for Isotope Dilution Mass Spectrometric Determination of Organic Serum Analytes (1999) (2)
Research in the development of PET radiopharmaceuticals. (1991) (2)
Androgen receptor-based imaging agents for the prostate: Synthesis and tissue distribution studies with tritium and fluorine-18 labeled androgens (1990) (2)
Certification of bilirubin SRM 916a (1990) (2)
A research resource in radionuclide research (2001) (2)
Evaluation of oral fluid testing devices (2009) (2)
The production of high specific activity Cu-64 as measured by ion chromatography (2010) (2)
Fluorine-18 labeled estrogens: Synthesis and biological evaluation of 11β and 17α substituted estradiols (1991) (2)
Synthesis and characterization of a neutral and lipophilic Ph3PN99mTcO3 complex (1995) (2)
RECEPTOR-BINDING RADIOPHARMACEUTICALS FOR IMAGING BREAST TUMORS: ESTROGEN-RECEPTOR INTERACTIONS AND SELECTIVITY OF TISSUE UPTAKE OF HALOGENATED ESTROGEN ANALOGS (1980) (2)
Fluorine-18 radiolabeling of SCK nanoparticles via copper-free click chemistry (2011) (2)
Measurement of myocardial perfusion with positron emission tomography and generator-produced Copper-62-PTSM (1990) (2)
Determination of total cholesterol in coconut oil: a new NIST cholesterol standard reference material (1989) (2)
REACTIONS WITH AROMATIC COMPOUNDS OF RECOILING BROMINE ATOMS FORMED FROM THE KRYPTON-76,77 → BROMINE-76,77 TRANSFORMATIONS. LIQUID-PHASE REACTIONS (1983) (2)
Reactions of recoil $sup 13$N atoms with some organic compounds in the solid and liquid phases (1973) (2)
The how and why of an accuracy base for proficiency testing programs. (1988) (2)
Imaging agents for brain corticosteroid receptors: Synthesis and tissue distribution of 21-[18F]fluoro-deacylcortivazol (1991) (2)
The Reactions with Benzene of Recoiling Bromine Atoms Formed from the 76,77Kr→ 76,77Br Transformations. Effects of Phase and Non-Inert Chemical Additives [1a] (1984) (2)
Differentiation in vivo of the sequential blood cell invasion following ureter obstruction of the rabbit kidney. (1989) (2)
Synthesis and Stabilities of the Ga(III) and In(III) Chelates of a New Diaminodithiol Bifunctional Ligand. (1998) (2)
First-pass extraction fraction of iodine-123 labeled perfusion tracers in living primate brain. (1994) (2)
Novel strategy for preparing Cu-64 nanoparticles with ultrahigh specific activity using metal-free click chemistry (2011) (2)
New methods of radiobromination. The sodium [77Br]bromide/tetrahalomethane/ triphenylphosphine reagent system (1982) (2)
Reactions of recoil bromine formed by the /sup 76/ /sup 77/Kr. -->. /sup 76/ /sup 77/Br system with simple hydrocarbons. Pressure and additive effects on gas-phase reactivity (1981) (2)
Synthesis of 2‐[18F]Fluoroestradiol, a Potential Diagnostic Imaging Agent for Breast Cancer: Strategies to Achieve Nucleophilic Substitution of an Electron‐Rich Aromatic Ring with [18F]F‐. (1999) (2)
Externally monitored leukocytic infiltration in myocardial infarcts (1976) (2)
Hypoxia imaging agent 64Cu-ATSM visualizes cancer stem cell-rich regions within tumors (2009) (2)
Improved labeling procedure of [18F]FFNP for in vivo imaging of progesterone receptors (2001) (2)
Oncologic imaging of tumor hypoxia by Cu-ATSM and correlating findings on Cu-ATSM PET scans to cellular markers that may predict for radiation response (2004) (1)
Chemistry, common sense and indium scanning agents. (1970) (1)
Interlaboratory studies on the analysis of hair for drugs of abuse (2000) (1)
Preparation, biodistribution, and micropet imaging of 45Ti-transferrin (2001) (1)
External quantification of myocardial metabolism with 11C-labeled fatty acids (1978) (1)
The Development of Definitive Methods for Organic Serum Constituents (1988) (1)
Assessment of 21 8 F ] Fluoro-1 • 6 a-Ethyl-19-Norprogesterone a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas (2008) (1)
Fluorine 18 spiroperidol simple 1 step synthesis purification and dosimetry (1984) (1)
Comparison of carbon-11 and fluorine-18 labeled (N-methyl)benperidol (NMB) in rodents using micropet imaging (2001) (1)
Biodistribution and metabolism of 16. cap alpha. -((/sup 18/F)-fluoro)-17. beta. -estradiol (1985) (1)
Positron emission tomography. Present status and future prospectives. (1991) (1)
Reactions of recoil iodine formed by the $sup 123$Xe $Yields$ $sup 123$I system with simple hydrocarbons, II. Pressure studies on the methane and ethane systems (1973) (1)
Letter: Preparation of 99mTc-fibrinogen. (1976) (1)
Molecular Imaging Probes for PET and SPECT (2005) (1)
A new synthesis of no-carrier-added [1-11C]DOPA (1986) (1)
Performance of a high-level copper-62 generator and remote system for [Cu-62]-Cu(PTSM) synthesis (1991) (1)
REACTIONS OF RECOIL BROMINE FORMED BY THE 76,77KR 76,77BR SYSTEMS WITH SIMPLE HYDROCARBONS (1981) (1)
Synthesis and evaluation in primates of (N‐[11C]methyl)‐benperidol as a pet tracer of cerebral D2 receptor binding (2001) (1)
60Cu-ATSM in Cancer of the Uterine Cervix (2008) (1)
Parameters affecting the labeling of 68Ga‐DTPA‐LDL: A potential radiopharmaceutical for in‐vivo imaging of tissue low‐density lipoprotein receptor activity with PET (1989) (1)
Automated synthesis of positron‐emitting radiopharmaceuticals based on generator‐produced radionuclides (1989) (1)
New chelates for the preparation of indium and gallium radiopharmaceuticals (1986) (1)
Copper‐64 radiolabeling and in vivo behavior of 4, 11‐bis(carboxymethyl)‐1, 4, 8, 11‐tetraazabicyclo[6.6.2]hexadecane (2001) (1)
Targeting Prostate Cancer with Small Molecule Inhibitors of Prostate-Specic Membrane Antigen (2012) (1)
Design considerations for foil windows for PET radioisotope targets (1992) (1)
N‐(2‐hydroxy‐3,5‐methylbenzyl)‐N′‐(2‐hydroxy‐5‐bromoacetamidobenzyl)‐ethylenediamine‐N,N′‐diacetic acid: A new bifunctional chelate for radiolabeling antibodies (1989) (1)
Preparation of gallium-68 radiopharmaceuticals for positron tomography. Progress report, November 1, 1978-October 31, 1979 (1978) (1)
Hot atom chemistry and radiopharmaceuticals (2012) (1)
Reactions of hot tritium atoms with the system, ethane and oxygen (1965) (1)
Radiopharmaceuticals Labeled with11C and18F: Considerations Related to the Preparation of11C-Palmitate (1982) (1)
16{alpha}-[18F]Fluoro-17{beta}-estradiol (FES) metabolite analyses in rodent tissue micro samples by solid-phase (SP) Florisil columns (2011) (1)
Gallium(III) Schiff-base complexes as potential PET agents for evaluation of multidrug resistance (MDR1) P-glycoprotein transport activity (1999) (1)
Potential of labeling monoclonal antibodies for positron emission tomography and magnetic resonance imaging. (1990) (1)
In vivo comparison of 16. cap alpha. -(/sup 77/Br)bromoestradiol-17. beta. and 16. cap alpha. -(/sup 125/I)Iodoestradiol-17. beta (1982) (1)
111In-Labeled Platelets for the Detection of Vascular Disorders in Animal Models (1983) (1)
Synthesis, Characterization, and Solid‐State Structure of a New Hexachelating Ligand and Its Complex with Gallium(III). (1989) (1)
Development of a Serum-Based Standard Reference Material with Certified Values for Homocysteine and Folate (2005) (1)
New N-substituted cyclens: Synthesis and comparative biodistribution studies of CU-64 complexes (2001) (1)
Sample Preparation Techniques in Analytical Chemistry. Somenath Mitra, editor. Hoboken, NJ: Wiley-Interscience, 2003, 476 pp., $89.95, hardcover. ISBN 0-471-32845-6. (2004) (1)
PRODUCTION OF 11C‐ACETYLENE BY METHANE PYROLYSIS (1980) (1)
Utility of Indium-111 Labelled Platelet Scans in Assessing the Dynamics of Thrombovascular Lesions. An Experience with 70 Patients (1979) (1)
REVIEW Gallium Radiopharmaceutical Chemistry (1989) (1)
Reaction intermediates in the chemistry of recoil carbon atoms (1968) (1)
Evaluation of Oral Fluid Testing Devices | NIST (2009) (1)
Analytical Quantification of Total Homocysteine and Folate in Human Serum in Relation to Cardiovascular Disease Risk Assessment and Prevention (2005) (1)
In vivo evaluation of 64Cu labeled PEGylated shell crosslinked nanoparticles (SCKs) as candidates for imaging and drug delivery (2008) (1)
In vivo comparison of 16 alpha(/sup 77/Br)bromoestradiol-17 beta and 16 alpha-(/sup 125/I)iodoestradiol-17 beta (1982) (1)
Improved scintigraphic detection of intravascular thrombi by a double radioisotope technique (1982) (1)
Radiolabeled Antibodies: Introduction and Metal Conjugation Techniques (1991) (1)
68Ga-Labeled DOTA-rhenium cyclized {alpha}-MSH peptide analog: A potential radiopharmaceutical for PET imaging of malignant melanoma (2007) (1)
Highly efficient radiolabeling/conjugation of PAMAM dendrimers with 18F labeled N-hydroxysuccinimide esters catalyzed by ion-ion interactions (2012) (1)
CCQM-K11.2 determination of glucose in human serum and CCQM-K12.2 determination of creatinine in human serum (2018) (1)
Determination of 19-norandrosterone in CCQM-P68. NIST results using an isotope dilution liquid chromatography/tandem mass spectrometry method (2007) (1)
11C-ACETATE PET IMAGING IN RENAL TUMOR (2007) (1)
Preparation of Radiopharmaceuticals Labeled with Metal Radionuclides (1992) (0)
A novel solid graphite target for the production of {sup 13}N-ammonia (1994) (0)
Radiopharmaceuticals for Clinical PET : Formul & ” on and Quality Control , Regulato ~ Issues and Professional (2001) (0)
Evaluation of Animal Models Using in-111-Labeled Platelets (1985) (0)
Imaging of “non‐standard” pet nuclides using the micropet (2001) (0)
Gamma Camera Detection of Experimental Pulmonary Emboli After Peripheral Injection of Indium-111 Labeled Platelets (1977) (0)
Radiopharmaceutical scheduling center with six pet scanners (2001) (0)
Assessing the efficacy of anti-diabetic therapies on myocardial glucose utilization in an animal model of type 2 diabetes (T2D) with PET (2008) (0)
POSITRON EMISSION TOMOGRAPHY, A RESEARCH OR CLINICAL TECHNIQUE?: XX (1984) (0)
Evolution of tumor hypoxia during radiotherapy predicts treatment response: implication of hypoxic imaging-guided IMRT (2002) (0)
Fluorine-18 labeled {sigma}2 receptor radiotracers for imaging breast cancer (2006) (0)
Imaging techniques with chelates of indium and gallium (1989) (0)
64Cu‐PTSM as an inhibitor of tumor recurrence (2001) (0)
USP STANDARDS FOR FLUMAZENIL C 11 INJECTION (1998) (0)
Assessment of a mathematical model to measure myocardial lactate oxidation using L3-[C-11]lactic acid and positron emission tomography (2005) (0)
In vivo evaluation of 64Cu radiolabeled gold nanocages for cancer PET imaging (2012) (0)
Preparation and use of /sup 123/I-labeled highly indinated fibrinogen for imaging deep-vein thrombi. [Dogs] (1976) (0)
Steroid hormones labeled with fluorine-18 and technetium-99m for imaging receptor-positive breast tumors (1993) (0)
Hybrid Image- and Blood-Sampling (HIBS) Input Function for Quantification of microPET Data (2008) (0)
Fluorine-18 labeled PPAR{gamma} antagonists for PET imaging studies (2008) (0)
Preparation of cyclopentadienyl tricarbonyl technetium-94m complexes (2001) (0)
Preparation of Alkyl and Aryl Chlorodifluoromethyl Ethers Using BrF3. (2008) (0)
11C-Acetate-PETを用いた前立腺癌再発診断 (2002) (0)
Targeted Molecular Imaging (2012) (0)
Total Serum Cholesterolby IsotopeDilution/MassSpectrometry:A Candidate DefinitiveMethod (2004) (0)
Evaluation of two σ2 PET tracers in mouse and human breast tumors (2007) (0)
Use of TricatecholamideLigandsto Alter the Biodistributionof Gallium-67: (2006) (0)
Comparison of In-ill-Labeled Platelets and lodinated Fibrinogen for the Detection of Deep Vein Thrombosis (2006) (0)
Halofluorination of Olefins: Elucidation of Reaction Characteristics and Applications in Labeling with the Positron-Emitting Radionuclide Fluorine-18. (1986) (0)
11C-LABELED RADIOPHARMACEUTICALS: SYNTHESIS AND HIGH PRESSURE LIQUID CHROMATOGRAPHY OF NICOTINIC -11C ACID AMIDK (1979) (0)
Multi-modal in cellulo evaluation of NPR-C targeted C-ANF-peptide and C-ANF-comb nanoparticles (2012) (0)
FLT vs FMAU as a marker of proliferation in pancreatic cancer (2007) (0)
208. Radiohalogenated estrogens: Imaging agents for human breast tumors (1982) (0)
ION-MOLECULE REACTIONS IN METHYL HALIDES, THE BEHAVIOR OF METHYL CATIONS AND HALIDE TRANSFER REACTIONS (1974) (0)
Comparison of methods used to radiolabel monoclonal antibodies (1985) (0)
Imaging of chemokine receptor in atherosclerosis and acute vascular injury with nanoparticle PET/CT (2012) (0)
General method for labeling proteins with $sup 11$C (1975) (0)
Kinetics of Copper-PTSMin IsolatedHearts: A Novel TracerforMeasuring BloodFlowwith Positron Emission Tomography (1989) (0)
Interstellar Molecules and Dense Clouds [Science 174(4041), 1083 (1971)] (1974) (0)
Dual isotope study of a novel {sigma}2 receptor ligand for PET and SPECT imaging studies of solid tumors (2007) (0)
Minoxidil and Cardiac Lesions (2005) (0)
Validation of the Conversion to New Instrumentation and the Modernization of Isotope Dilution Mass Spectrometric Definitive Methods for Organic Serum Analytes (1999) (0)
THE REACTIONS OF RECOIL (13)N ATOMS WITH SOME ORGANIC COMPOUNDS IN THE SOLID AND LIQUID PHASES (1975) (0)
3He BOMBARDMENT OF MANGANESE FOR THE PRODUCTION OF (1980) (0)
Evaluation of 64Cu-ATSM for an internal radiotherapy agent: 64Cu-ATSM treatment reduces CD133+ highly tumorigenic cells and metastatic ability of tumors (2010) (0)
FUNCTIONALIZATION OF SHELL CROSSLINKED NANOPARTICLES AND THEIR BIODISTRIBUTION ASSESSMENT (2007) (0)
The Installation of a P.E.T. Pharmacy at Washington University (2003) (0)
Production of N-13 ammonia using a solid graphite target and the {sup 12}C (d,n) {sup 13}N nuclear reaction (1994) (0)
Enzymatic Syntheses of 6-(4H-Selenolo[3,2-b]pyrrolyl)-L-alanine (IIIa), 4-(6H-Selenolo[2,3-b]pyrrolyl)-L-alanine (V), and 6-(4H-Furo[3,2-b]pyrrolyl)-L-alanine (IIIb). (1999) (0)
Gadolinium labeled antibodies for use in magnetic resonance imaging (MRI) (1986) (0)
Measuring Death Receptor 5 (DR5) occupancy in tumors using 64Cu-AMG 655 (2008) (0)
The mass spectra and isotopic purity of compounds proposed for use in the "master analytical scheme for the analysis of organic compounds in water (1980) (0)
Production of High Specific Activity Compounds Labeled with Short-Lived Radionuclides (2019) (0)
Conference Report: 2005 MIRT Workshop (2005) (0)
/sup 111/In platelet scintigraphy in cerebrovascular disease (1982) (0)
Preliminary evaluation of radiolabeled bitistatin as a potential agent for targeting integrins in tumor angiogenesis with pet (2001) (0)
Regioselectie N‐Substitution of Cyclen with Two Different Alkyl Groups: Synthesis of All Possible Isomers. (2003) (0)
16. cap alpha. -(/sup 77/Br)bromoestradiol-17. beta. : a high specific-activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors (1981) (0)
Comparison of biodistribution data from animal sacrifice and small animal imaging (2006) (0)
Retardation of 17-oxidation of 16 alpha-[18F]fluoroestradiol-17 beta by substitution of deuterium for hydrogen in the 17 alpha position(6). (1997) (0)
(F-18) halofluorination: A rapid and efficient method for the incorporation of radiofluorine into organic molecules (1985) (0)
Animal models for the evaluation of labeled monoclonal antibodies (1986) (0)
Intramolecular Effects of 1251 Decay in o-lodotyrosine' (1980) (0)
Current BER Scientists: Principal Investigators (2001) (0)
A simple approach to the synthesis of [C‐11]‐D‐mannitol and [C‐11]‐D‐glucitol (sorbitol) (2001) (0)
PRODUCTION OF ACTIVE MOLECULAR NITROGEN BY THE REACTION OF RECOIL $sup 13$N. (1968) (0)
11th International Symposium on Radiopharmacology at Washington University. (St. Louis, June 24-27, 1999). (1999) (0)
Use of an Animal Model System for Evaluating Labeled Monoclonal Antibodies (1988) (0)
Targeted Radiopharmaceuticals: Advances in Radiopharmacology and Radiopharmacy (2012) (0)
6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution. (1995) (0)
1104: In Vitro and In Vivo Assessment of 18F-FLT as a Proliferation Marker in Prostate Cancer Tumor Model (2004) (0)
Sites of direct and indirect halogenation of proteins (1977) (0)
Determination of serum cholesterol by a modification of the isotope dilution mass spectrometric definitive method [Erratum to document cited in CA111(7):53671m] (1990) (0)
Improved Production and Separation Technologies for Non-standard PET Radionuclides (2012) (0)
Quantitative Cardiac PET in Small Animals: Technical Aspects (2007) (0)
Labeling of receptor ligands and other compounds with halogen radionuclides (1989) (0)
Recent Trends in Radionuclide-Based Molecular Imaging (2006) (0)
A New Germanlum-6 BJGaIIIum-68 Generator (2006) (0)
111In-CHX-A"-DTPA-ReCCMSH(Arg11) SPECT melanoma imaging (2007) (0)
Radiosynthesis binding affinity and biodistribution of 3-[F-18]fluoro-N-({alpha},{alpha},{alpha}-trifluoro-m-tolyl)piperazine (FTFMPP), a radioligand for the Serotonin system (1996) (0)
The in vivo evaluation of copper‐64 radiolabeled DO2P, DO3P, and DOTP complexes (2001) (0)
Correlation of Regional Myocardial Blood Flow and Function with Myocardial Infarct Size During Acute Myocardial Ischemia in the Conscious Pig (2005) (0)
RADIOCHEMISTRY: BLEDTA: TUMOR LOCALIZATION BY A BLEOMYCIN ANALOGUE CONTAINING A METAL‐CHELATING GROUP (1980) (0)
Parametric imaging of dynamic microPET data (2007) (0)
Comparison of maximum likelihood factor analysis (MLFA) applied to FBP and MAP reconstructed mice microPET data (2007) (0)
Production of positron-emitting radiopharmaceuticals. (1988) (0)
NCA (/sup 18/F)-16. cap alpha. -fluoroestradiol-17. beta. : Optimization of yield and quality control by HPLC (1985) (0)
The use of /sup 11/C-glucose and positron emission tomography to measure brain glucose metabolism (1985) (0)
N-alkylated analogues of [F-18]benperidol as dopaminergic D-2 receptor ligands (1994) (0)
Tricatecholamide analogs of enterobactin as Ga and in radiopharmaceuticals (1981) (0)
Small Project Final Quarterly Report (2013) (0)
(2R*,3S*)-1-(125I)IODO-2,3-BIS(4-HYDROXYPHENYL)PENTANE ((125I)IODONORHEXESTROL), AND (2R*,3S*)-1-(77BR)BROMO-2,3-BIS(4-HYDROXYPHENYL)PENTANE ((77BR)BROMONORHEXESTROL), TWO Γ-EMITTING ESTROGENS THAT SHOW RECEPTOR-MEDIATED UPTAKE BY TAR (1983) (0)
REGIONAL INTRACELLUAR pH SHIFE A PROPOSED NEW MECHANISM FOR RADIOPHARMACEUTICAL UPIAKE IN BRAIN AND OTHER TISSUES (1980) (0)
Brain blood volume, hematocrit, and acidbase status measured with positron CT scanning (1978) (0)
Investigationof Physicochemicaland In-Vivo Behaviorof DiastereomericIron-59, Gaffium 68,andIndium-i11-EHPGTrivalent Metal Complexes (1990) (0)
Analysis of metabolites of Cu-64 labeled DOTA PEGylated star-like copolymeric nanoparticles (2009) (0)
Indium labelled leukocytes as markers of inflammatory cellular changes in hydronephrosis (1984) (0)
AND USE OF 1231-LABELED HIGHLY IODINATED FIBRINOGEN FOR IMAGING DEEP-VEIN THROMBI (1975) (0)
Letter: Preparation of 125 I-fibrinogen. (1975) (0)
Utility of a Polyarginine Peptide To Mediate Intracellular Particle Entry In Vitro and Following Intratracheal Delivery. (2009) (0)
PET and molecular imaging oral abstract session (2005) (0)
Wall effects in gas-phase recoil tritium chemistry (1965) (0)
Translational Applications of Molecular Imaging and Radionuclide Therapy (2005) (0)
PICTURE THIS : RADIOMETALS IN MEDICINE (1998) (0)
[Br-76] 16{alpha},17{alpha}-Dioxolane progestin for breast tumor imaging and radiotherapy: Synthesis and tissue biodistribution study (2007) (0)
Exponential Infusion of Positron-emitting Radionuclides (1980) (0)
Scintigraphic diagnosis of experimental pulmonary embolism with /sup 111/In-labeled platelets. [/sup 99m/Tc, dogs] (1977) (0)
PET - radiopharmaceutical facilities at Washington University Medical School - an overview (1994) (0)
Certification of Creatinine in a Human Serum Reference Material by Gas Chromatography/Mass Spectrometry and Liquid Chromatography/Mass Spectrometry (2007) (0)
Targeted Optical Molecular Imaging with Cytate: From Bench toward Bedside (2012) (0)
THE-122Xe-122 SYSTEM: A GENERATOR FOR THE 3.62 MIN POSITRON EMITITER (1979) (0)
Comparison of a Cu-64 labeled peptide (CANF) with nanoparticle agent in a murine hind limb ischemia model (2010) (0)
Binding of 16 alpha-[18F]fluoro-17 beta-estradiol to alphafetoprotein in Sprague-Dawley female rats affects blood levels. (1990) (0)
Production of radiopharmaceuticals for positron emission tomography via laboratory robotics (1987) (0)
New Approaches to the Labeling of Estrogen Useful for PET. (1997) (0)
Potential agents for regional cerebral blood flow measurement using PET. (1987) (0)
THE SYNTHESIS OF le‐LABELED 17β‐HYDROXY‐2‐TELLURA‐A‐NOR‐5α‐ANDROSTANE F.F (1980) (0)
REACTIONS OF RECOIL IODINE FORMED BY THE (123)XE-(123)I SYSTEM WITH SIMPLE HYDROCARBONS PART 2, PRESSURE STUDIES ON THE METHANE AND ETHANE SYSTEMS (1973) (0)
The Relative Reactivities of Ethane, Ethane-d6, n-Butane and Neopentane towards ‘Hot' Tritium Atoms (1974) (0)
Development of fully automated ion-exchange approach for processing generator produced 68Ga (2012) (0)
EFFECTS OF GAMMA RADIATION ON MASTIC SEALANTS. (1967) (0)
Preparation of radiopharmaceuticals labeled with metal radionuclides. Progress report, July 1, 1988--June 30, 1992 (1992) (0)
Myelin imaging with C-11 labeled diphenylmethanol and positron emission tomography (1985) (0)
Comparisonof Two Isotope Dilution / Mass SpectrometricMethodsfor Determinationof TotalSerum Cholesterol (2004) (0)
Nanoparticle PET imaging of natriuretic peptide clearance receptor in a rabbit atherosclerosis model (2012) (0)
Synthesis and uptake of no carrier-added C-11 labeled putrescine in male rat prostate (1985) (0)
Preparation of gallium-68 radiopharmaceuticals for positron tomography. Progress report, November 1, 1977-October 31, 1980 (1980) (0)
Synthesis and In Vivo Evaluation of 2 High-Affinity 76Br-Labeled s2-Receptor Ligands (2006) (0)
Determination of cholesterol in human serum standard reference materials by isotope dilution/mass spectrometry (1988) (0)
Development of Methods and Standards for the Analysis of Human Hair for Drugs of Abuse | NIST (1991) (0)
The formation of excited ethane in the tritium recoil labelling reaction (1966) (0)
CCQM K6.2 determination of total cholesterol in human serum (2018) (0)
Accelerator production of copper-64 for pet and radiotherapy (1997) (0)
Positron Emission Tomography (PET) (1990) (0)
MicroPET imaging of steroid hormone receptors and response to hormonal therapy in a mouse model of breast cancer (2011) (0)
of 13NH3 on Metabolic Factors and Its Implications for Quantitative Assessment of Perfusion (2005) (0)
EXCITATION FUNCTION FOR THE 14N(p,α)11C REACTION UP TO 15 MeV (1979) (0)
CARBON-11 LABELING OF THE PSYCHOACTIVE DRUG O-METHYL-BUFOTENINE AND ITS DISTRIBUTION IN THE ANIMAL ORGANISM (1979) (0)
Comparison ofTwoIsotope Dilution/MassSpectrometric Methods for Determination ofTotalSerumCholesterol (1982) (0)
Use of positron emission tomography in drug evaluation; applications and examples (1992) (0)
Advances in the robotic production of radiopharmaceuticals (1994) (0)
Synthesis of New Multidentate Ligands for the Coordination of Indium( III), Gadolinium(III) and Thorium(IV). (1992) (0)
Differential efficacy of metformin and rosiglitazone monotherapy on myocardial substrate metabolism (2009) (0)
POSITRON EMITTING RADIOPHARMACEUTICALS (1978) (0)
The Recoil tritium labelling reaction as a function of tritium energy and molecular size (1967) (0)
Development of a Standard ReferenceMaterial for Metabolomics Research (2013) (0)
Positron emission tomography imaging chemokine receptors in atherosclerosis and acute vascular injury (2011) (0)
To Appear in CHEMICAL REVIEWS, Vol. 99, No. 9. (1999) (0)
222: In Vitro and in Vivo Evaluation of 18F-Fluoroacetate: A Potential Acetate Analog for Tumor Imaging (2005) (0)
1116-24 Assessment of myocardial perfusion and metabolism in normal and diabetic rats by microPET imaging (2004) (0)
An ultra-compact {sup 13}N-ammonia generator (1994) (0)
From Cyclotron to Patient via HPLC (1986) (0)
Characterization of 64Cu-labeled AMG 655 as a PET tracer for imaging death receptor 5 (DR5) in tumor (2008) (0)
REACTIONS OF RECOIL BROMINE FORMED BY THE 76,77KR → 76,77BR SYSTEMS WITH SIMPLE HYDROCARBONS. SOLID‐PHASE REACTIONS (1981) (0)
A Rapid and Efficient Method for the Fluoroalkylation of Amines and Amides. Development of a Method Suitable for Incorporation of the Short-Lived Positron Emitting Radionuclide Fluorine-18. (1987) (0)
Optimization of 16{alpha}-[18F]fluoroestradiol synthesis with optimal effective specific activity for small animal studies (2011) (0)
RADIOCHEMISTRy AND RADIOPHARMACEUTICAL.S [18FF-Labeled 3-Deoxy-3-Fluoro-D-Glucose: Synthesis and Preliminary Biodistribution Data (2006) (0)
A very simple, reliable and economic set-up for [11C]-methyl iodide synthesis (2001) (0)
PREPARATION OF 11COC12 (1979) (0)
Synthesis and evaluation of radiolabeleled inhibitors of inducible nitric oxide synthase (2001) (0)
PEGYLATION OF SHELL CROSSLINKED NANOPARTICLES AND THEIR BIODISTRIBUTION ASSESSMENT (2007) (0)
Synthesis and in vivo evaluations of [11C] KMW01 as a radiotracer for imaging PPAR-{alpha} receptors (2011) (0)
64Cu-labeled natriuretic peptide: A promising tracer for atherosclerotic plaque molecular imaging with PET (2007) (0)
Kinetic analysis of 16α-[18F]fluoro-17β-estradiol (FES) in STAT1-/- mammary tumors following treatment with fulvestrant (2011) (0)
1554: In Vitro and in Vivo Assessment of 18F-Fluorothymidine for Monitoring Tumor Proliferation of Prostate Cancer Following Anticancer Therapy with Docetaxel (2006) (0)
Fujibayashi radiotherapy with copper-64-diacetyl-bis(N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma Nuclear Medicine and Biology (2011) (0)
Optimization of Y-86 production via an automated system (2011) (0)
RADIOCHEMISTRY: THE ATTACHMENT OF METAL-CHELATING GROUPS TO PROTEINS (1979) (0)
Development and Evaluation of a Re e Measurement Procedure for the Determination of Total 3,3',S-Triiodothyronine in Human Serum Using Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry (2004) (0)
IDENTIFICATION OF METABOLITES OF IN-111-DTPA-MONOCLONAL ANTIBODIES AND ANTBODY FRAGMENTS IN VIVO (1994) (0)
16a-[77Br]Bromoestradiol-17/3: A High Specific-Activity, Gamma-Emitting (2006) (0)
Modern Imaging Technology: Recent Advances (2004) (0)
Radiotoxicity of bromine and fluorine radiolabled estrogens in MCF‐7 cell culture (2001) (0)
Synthesis, 18F radiolabeling and in vivo biodistribution of 6-(2-fluoropropyl)-4-methylpyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael J. Welch?

Michael J. Welch is affiliated with the following schools:

Michael J. Welch's Academic­Influence.com Rankings

Why Is Michael J. Welch Influential?

Michael J. Welch's Published Works

Published Works

What Schools Are Affiliated With Michael J. Welch?

Michael J. Welch's AcademicInfluence.com Rankings